Decreased Plasma BDNF Levels of Patients with Somatization Disorder

키워드

참고문헌 (58)

1. Katon W, "Somatization : a spectrum of severity", Am J Psychiatry, 148, pp.34~40 (1991)
2. Rief W, "Somatization symptoms and hypochondriacal features in the general population", Psychosom Med, 63, pp.595~602 (2001)
3. Lipowski ZJ, "Somatization : the concept and its clinical application", Am J Psychiatry, 145, pp.1358~1368 (1988)
4. Barsky AJ, "Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity", Arch Gen Psychiatry, 62, pp.903~910 (2005)
5. Anglade P, "Neuronal plasticity and Parkinson disease", Mol Chem Neuropathol, 24, pp.251~255 (1995)
6. Thoenen H, "Neurotrophins and neuronal plasticity", Science, 270, pp.593~598 (1995)
7. Lindsay RM, "Neurotrophic factors : from molecule to man", Trends Neurosci, 17, pp.182~190 (1994)
8. Lewin GR, "Physiology of the neurotrophins", Annu Rev Neurosci, 19, pp.289~317 (1996)
9. Malberg JE, "Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus", J Neurosci, 20, pp.9104~9110 (2000)
10. Zhivolupov SA, "The prognostic significance of brain-derived neurotrophic factor (BDNF)for phobic anxiety disorders, vegetative and cognitive impairments during conservative treatment including adaptol of some functional and organic diseases of nervous system", Zh Nevrol Psikhiatr Im S S Korsakova, 112, pp.37~41 (2012)
11. Satomura E, "Correlations between brain-derived neurotrophic factor and clinical symptoms in medicated patients with major depression", J Affect Disord, 135, pp.332~335 (2011)
12. Brondino N, "Decreased NT-3 plasma levels and platelet serotonin content in patients with hypochondriasis", J Psychosom Res, 65, pp.435~439 (2008)
13. Deveci A, "Serum brainderived neurotrophic factor levels in conversion disorder : comparative study with depression", Psychiatry Clin Neurosci, 61, pp.571~573 (2007)
14. Zhang XY, "The interplay between BDNF and oxidative stress in chronic schizophrenia", Psychoneuroendocrinology, 51, pp.201~208 (2015)
15. Valiente-Gomez A, "Comparison of serum BDNF levels in deficit and nondeficit chronic schizophrenia and healthy controls", Psychiatry Res, 220, pp.197~200 (2014)
16. Radahmadi M, "Effects of different timing of stress on corticosterone, BDNF and memory in male rats", Physiol Behav, 139, pp.459~467 (2015)
17. Niknazar S, "Comparison of the adulthood chronic stress effect on hippocampal BDNF signaling in male and female rats", Mol Neurobiol, 53, pp.4026~4033 (2016)
18. Tao F, "Expression of BDNF mRNA in nasal mucosa with allergic rhinitis rat model", Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 24, pp.224~226 (2010)
19. Zeilinger S, "The effect of BDNF gene variants on asthma in German children", Allergy, 64, pp.1790~1794 (2009)
20. Constandil L, "Involvement of spinal cord BDNF in the generation and maintenance of chronic neuropathic pain in rats", Brain Res Bull, 86, pp.454~459 (2011)
21. Duan B, "PI3-kinase", Akt pathway-regulated membrane insertion of acid-sensing ion channel 1a underlies BDNF-induced pain hypersensitivity, 2012, pp.32, 6351~6363
22. Herradon G, "Changes in BDNF gene expression correlate with rat strain differences in neuropathic pain", Neurosci Lett, 420, pp.273~276 (2007)
23. Li CQ, "Brain derived neurotrophic factor(BDNF)contributes to the pain hypersensitivity following surgical incision in the rats", Mol Pain, 4, pp.27~ (2008)
24. Merighi A, "BDNF as a pain modulator", Prog Neurobiol, 85, pp.297~317 (2008)
25. Obata K, "BDNF in sensory neurons and chronic pain", Neurosci Res, 55, pp.1~10 (2006)
26. Stefani LC, "BDNF as an effect modifier for gender effects on pain thresholds in healthy subjects", Neurosci Lett, 514, pp.62~66 (2012)
27. Sivik T, "Alexithymia and hypersensitivity to touch and palpation", Integr Physiol Behav Sci, 28, pp.130~136 (1993)
28. Wilhelmsen I, "Somatization, sensitization, and functional dyspepsia", Scand J Psychol, 43, pp.177~180 (2002)
29. Fass R, "Functional heartburn: what it is and how to treat it", Gastrointest Endosc Clin N Am, 19, pp.23~33 (2009)
30. Koh KB, "Serotonin-related gene pathways associated with undifferentiated somatoform disorder", Psychiatry Res, 189, pp.246~250 (2011)
31. Han C, "Fluoxetine versus sertraline in the treatment of patients with undifferentiated somatoform disorder: a randomized, open-label, 12-week, parallelgroup trial", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.437~444 (2008)
32. Koh KB, "Effect of tryptophan hydroxylase gene polymorphism on aggression in major depressive disorder and undifferentiated somatoform disorder", J Clin Psychiatry, 73, pp.e574~e579 (2012)
33. Van Kempen GM, "Biochemical measures in patients with a somatoform pain disorder, before, during, and after treatment with amitriptyline with or without flupentixol", Biol Psychiatry, 31, pp.670~680 (1992)
34. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders", American Psychiatric Association, ~ (1994)
35. Chang YH, "Genetic variants of the BDNF and DRD3 genes in bipolar disorder comorbid with anxiety disorder", J Affect Disord, 151, pp.967~972 (2013)
36. Park MH, "Preliminary study of anxiety symptoms, family dysfunction, and the brain-derived neurotrophic factor (BDNF) Val66Met genotype in offspring of parents with bipolar disorder", J Psychiatr Res, 61, pp.81~88 (2014)
37. Brunoni AR, "BDNF blood levels after non-invasive brain stimulation interventions in major depressive disorder: a systematic review and meta-analysis", World J Biol Psychiatry, 16, pp.114~122 (2014)
38. Yoshimura R, "Blood levels of brain-derived neurotrophic factor (BDNF) in major depressive disorder", Seishin Shinkeigaku Zasshi, 112, pp.982~985 (2010)
39. Lommatzsch M, "The impact of age, weight and gender on BDNF levels in human platelets and plasma", Neurobiol Aging, 26, pp.115~123 (2005)
40. Gervasoni N, "Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode", Neuropsychobiology, 51, pp.234~238 (2005)
41. Shimizu E, "Alterations of serum levels of brain-derived neurotrophic factor(BDNF)in depressed patients with or without antidepressants", Biol Psychiatry, 54, pp.70~75 (2003)
42. Lin CF, "Correlations between sexual dysfunction, depression, anxiety, and somatic symptoms among patients with major depressive disorder", Chang Gung Med J, 35, pp.323~331 (2012)
43. Woo JM, "Importance of remission and residual somatic symptoms in health-related quality of life among outpatients with major depressive disorder : a cross-sectional study", Health Qual Life Outcomes, 12, pp.188~ (2014)
44. Garcia-Campayo J, "Relationship of somatic symptoms with depression severity, quality of life, and health resources utilization in patients with major depressive disorder seeking primary health care in Spain", Prim Care Companion J Clin Psychiatry, 10, pp.355~362 (2008)
45. Romera I, "Generalized anxiety disorder, with or without comorbid major depressive disorder, in primary care: prevalence of painful somatic symptoms, functioning and health status", J Affect Disord, 127, pp.160~168 (2010)
46. Stahl SM, "Analysis of the rate of improvement of specific psychic and somatic symptoms of general anxiety disorder during long-term treatment with venlafaxine ER", CNS Spectr, 12, pp.703~711 (2007)
47. Deschenes SS, "Associations between diabetes, major depressive disorder and generalized anxiety disorder comorbidity, and disability: findings from the 2012 Canadian Community Health Survey - Mental Health (CCHS-MH)", J Psychosom Res, 78, pp.137~142 (2015)
48. Hunt C, "Generalized anxiety disorder and major depressive disorder comorbidity in the National Survey of Mental Health and Well-Being", Depress Anxiety, 20, pp.23~31 (2004)
49. Phillips AC, "Major depressive disorder, generalised anxiety disorder, and their comorbidity:associations with cortisol in the Vietnam Experience Study", Psychoneuroendocrinology, 36, pp.682~690 (2011)
50. Cubeddu A, "Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome", Psychoneuroendocrinology, 36, pp.523~530 (2011)
51. Katerberg H, "The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessivecompulsive disorder (OCD)", Am J Med Genet B Neuropsychiatr Genet, 150B, pp.1050~1062 (2009)
52. Simsek S, "BDNF and cortisol levels in children with or without post-traumatic stress disorder after sustaining sexual abuse", Psychoneuroendocrinology, 56, pp.45~51 (2015)
53. Shou-Sen Shi, "Acute Stress and Chronic Stress Change Brain-Derived Neurotrophic Factor (BDNF) and Tyrosine Kinase- Coupled Receptor (TrkB) Expression in Both Young and Aged Rat Hippocampus", Yonsei Medical Journal, 51(5), pp.661~671 (2010), 연세대학교의과대학
54. Tognoli C, "Acute stress alters transcript expression pattern and reduces processing of proBDNF to mature BDNF in Dicentrarchus labrax", BMC Neurosci, 11, pp.4~ (2010)
55. van Winkel M, "Impact of variation in the BDNF gene on social stress sensitivity and the buffering impact of positive emotions : replication and extension of a gene-environment interaction", Eur Neuropsychopharmacol, 24, pp.930~938 (2014)
56. Karege F, "Decreased serum brain-derived neurotrophic factor levels in major depressed patients", Psychiatry Res, 109, pp.143~148 (2002)
57. Pan W, "Transport of brainderived neurotrophic factor across the blood-brain barrier", Neuropharmacology, 37, pp.1553~1561 (1998)
58. Karege F, "Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets", Neurosci Lett, 328, pp.261~264 (2002)

관련 논문AI추천